Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis.
Mol Cancer. 2022 Mar 30;21(1):89. doi: 10.1186/s12943-022-01542-8.
Mol Cancer. 2022.
PMID: 35354467
Free PMC article.
Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study, a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRC.
Bianconi D, Herac M, Posch F, Schmeidl M, Unseld M, Kieler M, Brettner R, Müllauer L, Riedl J, Gerger A, Scheithauer W, Prager G.
Bianconi D, et al. Among authors: schmeidl m.
Ther Adv Med Oncol. 2020 Aug 18;12:1758835920928635. doi: 10.1177/1758835920928635. eCollection 2020.
Ther Adv Med Oncol. 2020.
PMID: 32922518
Free PMC article.
Item in Clipboard
SERPINB7 Expression Predicts Poor Pancreatic Cancer Survival Upon Gemcitabine Treatment.
Bianconi D, Herac M, Spies D, Kieler M, Brettner R, Unseld M, Fürnkranz K, Famler B, Schmeidl M, Minichsdorfer C, Zielinski C, Heller G, Prager GW.
Bianconi D, et al. Among authors: schmeidl m.
Transl Oncol. 2019 Jan;12(1):15-23. doi: 10.1016/j.tranon.2018.08.019. Epub 2018 Sep 20.
Transl Oncol. 2019.
PMID: 30245304
Free PMC article.
Item in Clipboard
Cite
Cite